Get email alerts when NTRA insiders make a move — free, no credit card

NTRA Insider Trading & Form 4 Activity

Natera, Inc.
Last filing: Oct 23, 2026·1 day ago
NEUTRAL · LAST 90 DAYS
0%
buyers
$0
0 buys
$0
0 sells
$0
net buying
0
insiders
Tracking NTRA insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
—
$71.3M
-$71.3M
Sheena Jonathan
Director
—
$16.7M
-$16.7M
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
—
$8.6M
-$8.6M
Chapman Steven Leonard
CEO AND PRESIDENT
—
$3.4M
-$3.4M
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
—
$2.6M
-$2.6M
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
—
$1.5M
-$1.5M
Rabinowitz Daniel
SEC. AND CHIEF LEGAL OFFICER
—
$575K
-$575K

Recent transactions

Every Form 4 transaction for NTRA, newest first.

SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
605 sh @ $411.32
$249K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
165 sh @ $416.67
$69K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
255 sh @ $415.67
$106K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
125 sh @ $413.05
$52K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
211 sh @ $412.20
$87K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
200 sh @ $406.50
$81K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
627 sh @ $409.89
$257K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 21·Filed Oct 23·EDGAR ↗
962 sh @ $408.26
$393K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
90 sh @ $404.25
$36K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
280 sh @ $401.29
$112K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
50 sh @ $405.15
$20K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
215 sh @ $399.34
$86K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
142 sh @ $398.95
$57K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
80 sh @ $409.36
$33K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
98 sh @ $409.34
$40K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
35 sh @ $406.63
$14K
SELL10b5-1
Sheena Jonathan · Director
Tx Oct 16·Filed Oct 20·EDGAR ↗
60 sh @ $401.62
$24K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
600 sh @ $390.21
$234K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
300 sh @ $391.58
$117K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
6,309 sh @ $402.23
$2.5M
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
5,974 sh @ $401.42
$2.4M
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
1,400 sh @ $406.63
$569K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
6,274 sh @ $405.18
$2.5M
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
3,800 sh @ $407.27
$1.5M
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
3,858 sh @ $403.27
$1.6M
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
10,321 sh @ $404.64
$4.2M
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
2,000 sh @ $408.24
$816K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
1,100 sh @ $397.16
$437K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
714 sh @ $389.84
$278K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
1,900 sh @ $396.30
$753K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
793 sh @ $399.31
$317K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
2,671 sh @ $400.31
$1.1M
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
286 sh @ $388.32
$111K
EXERCISE10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
50,000 sh @ $10.41
$521K
SELL10b5-1
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 15·Filed Oct 16·EDGAR ↗
800 sh @ $393.47
$315K
GIFT
Rabinowitz Matthew · EXECUTIVE CHAIRMAN
Tx Oct 7·Filed Oct 9·EDGAR ↗
6,000 sh
—
SELL10b5-1
Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS
Tx Oct 1·Filed Oct 2·EDGAR ↗
1,846 sh @ $415.07
$766K
SELL10b5-1
Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS
Tx Oct 1·Filed Oct 2·EDGAR ↗
200 sh @ $411.62
$82K
SELL10b5-1
Chapman Steven Leonard · CEO AND PRESIDENT
Tx Oct 1·Filed Oct 2·EDGAR ↗
1,273 sh @ $413.31
$526K
SELL10b5-1
Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS
Tx Oct 1·Filed Oct 2·EDGAR ↗
954 sh @ $413.11
$394K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
2,734 sh @ $387.65
$1.1M
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
2,175 sh @ $386.71
$841K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
2,846 sh @ $387.74
$1.1M
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
1,341 sh @ $388.76
$521K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
2,300 sh @ $386.64
$889K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
1,935 sh @ $389.71
$754K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
1,293 sh @ $388.71
$503K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
2,320 sh @ $389.69
$904K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
110 sh @ $390.42
$43K
SELL10b5-1
Sheena Jonathan · Director
Tx Sep 23·Filed Sep 25·EDGAR ↗
400 sh @ $385.10
$154K

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About NTRA insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for NTRA from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying NTRA always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Natera, Inc. (NTRA) when they form.

Where does NTRA insider trading data come from?

Every Form 4 filing for NTRA is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai